Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia

IMPORTANCE: Use of empirical broad-spectrum antibiotics for pneumonia has increased owing to concern for resistant organisms, including methicillin-resistant Staphylococcus aureus (MRSA). The association of empirical anti-MRSA therapy with outcomes among patients with pneumonia is unknown, even for...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Intern Med
Autori principali: Jones, Barbara Ellen, Ying, Jian, Stevens, Vanessa, Haroldsen, Candace, He, Tao, Nevers, McKenna, Christensen, Matthew A., Nelson, Richard E., Stoddard, Gregory J., Sauer, Brian C., Yarbrough, Peter M., Jones, Makoto M., Goetz, Matthew Bidwell, Greene, Tom, Samore, Matthew H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042818/
https://ncbi.nlm.nih.gov/pubmed/32065604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.7495
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi